Navigation Links
The Economist's Pharma Summit 2013: 'Back to Basics - the Real Business of Pharma'
Date:1/29/2013

LONDON, January 29, 2013 /PRNewswire/ --

~ Tweet your questions ahead of The Pharma Summit 2013 at @EG_Healthcare ~

Should Pharma cut its losses and get out of R&D, or does it still have a role to play in medical research?

The Economist Events is holding its 19th Annual Pharma Summit 2013 in London on Thursday, 28th February 2013. The summit will be held at The Dorchester Hotel,  Park Lane London, W1K 1QA from 8:30am to 5:00pm.

The Pharma Summit has become an established key global event for the healthcare industry, attracting and gathering some of the most influential names in the global pharmaceutical and healthcare industries. This year's theme 'Back to basics -the real business of Pharma' will assess the challenges the industry is facing as the last remaining blockbuster drugs reach the end of their patent protection.

"This year's conference theme is particularly pertinent." said Edwin Moses , a panel speaker and the CEO of Ablynx. "We have to start looking beyond the patent cliff when assessing the health of the Pharma industry, especially in light of tight healthcare budgets and R&D productivity. The Pharma Summit brings together some of the industry's leading experts who have a unique insight into these issues and the significant trends in the space at the moment."

The event will focus on a number of topical issues, such as the change in Big Pharma business models post-blockbuster, the shifts in the drug discovery and development paradigm, and Pharma in an age of austerity, explored through a series of thought provoking keynotes, panel discussions, interviews and debates.

Join us on Twitter @EG_Healthcare to get the latest updates on The Pharma Summit, submit your questions, and join in with discussions on the day.

Among others, you will hear from:  

  • Severin Schwan , Chief Executive Officer, Roche Group
  • Klaus Wilgenbus, Corporate Senior Vice-president, Boehringer Ingelheim
  • Edwin Moses , Chief Executive Officer, Ablynx
  • Anders Gersel Pedersen , Executive Vice-president, Drug Development, Lundbeck
  • Jane Griffiths , Company Group Chairman, Janssen Europe , Middle East and Africa, Johnson & Johnson
  • Nigel Clerkin, Executive Vice-president and Chief Financial Officer, Elan Corporation plc
  • Kate Bingham , Managing Partner, SV Life Sciences Advisers LLP
  • Paul Stoffels , Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
  • Roch Doliveux, Chief Executive Officer and Chairman of the Executive Committee, UCB

For more information and to view the full programme please visit: http://www.thepharmasummit.com  

About The Economist Events

The Economist Events is part of the Management Thinking division of The Economist Group. Our philosophy is to tackle issues with a forward-looking, uniquely global perspective. We create events that are for the intellectually curious: those people who enjoy ideas and those who are passionate about the issues that define our world.

This press release has been issued by M:Communications on behalf of The Economist Events' The Pharma Summit 2013.

Contact Information:

For further information on event registration or to request interviews with any of the speakers at The Pharma Summit 2013, please contact Amber Bielecka , Hollie Vile or Claire Dickinson within the official press office:

M:Communications, official press office for The Economist Healthcare Events

E: pharmasummit2013@mcomgroup.com

Tel: +44-(0)20-7920-2360


'/>"/>
SOURCE The Economist’s Pharma Summit
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
2. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
3. CPhI Southeast Asia Broadens Focus to Highlight Vibrant ASEAN Pharma Market
4. Study Delivers Investment Benchmarks across Key New Product Launch Activities in Pharmaceutical Sector
5. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
6. Drugstore Lobby Poll of Seniors: Mail-Service Pharmacies Cost Less than Community Drugstores
7. Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics
8. Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.
9. The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
10. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
11. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... 28, 2016  The blood testing market in ... to Kalorama Information and The Freedonia Group in a ... acid testing.  The healthcare research firm said that ... blood collection stations and in improving testing at the ... report, Blood Testing Market in China ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the dentists ... dentistry is a fast-growing field as more patients are discovering the many different ways ... about the options currently available to them and which ones might work for their ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market leader ... led by Eastside Partners, with participation from existing investor Martin Ventures. The ... accelerate its technology and product roadmap. , “Jvion is experiencing significant ...
(Date:4/29/2016)... ... ... Regenerative Medicine Solutions (RMS) scored 94.8124 out of 100 on ... place for Tampa’s Best Places to Work. They were ranked in the Big Category, ... for our team,” says RMS Human Resources Manager Irene Miller. “We work hard to ...
(Date:4/29/2016)... Newport Beach, CA (PRWEB) , ... April 29, 2016 , ... ... Dr. Jane L. Frederick, Dr. Sanaz Ghazal, and Dr. Daniel A. Potter -- are ... the Society for Assisted Reproductive Technology (SART). In April, SART published the ...
Breaking Medicine News(10 mins):